Abreos Biosciences is a precision medicine company based in San Diego, California. Abreos' core technology is the Veritope platform, based on peptide antigen mimetics (mimetopes) that bind to antibodies in the antigen binding site.

 

Veritopes have several advantages as capture agents over antibodies or recombinant protein antigens.  They are inexpensive to produce, chemically stable with long shelf lives, and easy to conjugate or integrate into different immunoassays in both laboratory based or point of care settings.

 

Abreos already holds a portfolio of Veritopes fitting many leading biologic drugs and can quickly and cost effectively produce to new targets. One main application of the Veritope technology is the monitoring of biologic drug circulating in blood.

 

Abreos has recently partnered with Lifeassays, a Swedish Point-of-care specialist, and formed the joint venture Aegirbio to commercialize therapeutic drug monitoring diagnostics in the autoimmune, oncology and neurology space.

​

​